November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

November 14, 2024

Heat Waves Spike Atrial Fibrillation Risk

Reuters

November 11, 2024

Cardiac Patients Sought Sex Advice, Found Silence

While 76% of cardiac patients reported sexual health affecting their mood and well-being, only 5% received counseling on the topic, according to new survey data presented at AHA Scientific Sessions 2024.

Conexiant

November 08, 2024

When Cancer and Cardiovascular Disease Intersect

The annual Global Cardio-Oncology Summit brings together health-care professionals from diverse disciplines including members of the International Cardio-Oncology Society, the only multidisciplinary p...

The ASCO Post

November 07, 2024

Risk of Ischemic Cardiotoxicity With Aromatase Inhibitors in Postmenopausal Patients With Early Breast Cancer

As reported in The Lancet Oncology by Lund et al, a Danish prospective cohort study showed no increased risk of ischemic cardiotoxicity with the use of aromatase inhibitor treatment in postmenopausal ...

The ASCO Post

November 07, 2024

When Cancer and Cardiovascular Disease Intersect

The annual Global Cardio-Oncology Summit brings together health-care professionals from diverse disciplines including members of the International Cardio-Oncology Society, the only multidisciplinary p...

The ASCO Post

November 07, 2024

Words That Shut Down Patient Conversations

Certain words can unintentionally disempower patients, according to a perspective outlining language clinicians should avoid in conversations with seriously ill patients.

Conexiant

November 05, 2024

Resection of Stage I to III Thymic Tumors in High-Volume U.S. Centers

In a study reported in a research letter in JAMA Surgery, Sakowitz et al found that R0 resection was more commonly achieved in patients with stage I to III thymic tumors who received surgery at high-v...

The ASCO Post

October 31, 2024

Younger Hearts, Higher Stakes in TAVR

In a study of 139,695 TAVR patients, those under 65 showed a striking 28.2% one-year readmission rate and nearly 10% mortality - ten times higher than their counterparts in previous low-risk trials, suggesting careful patient selection remains crucial for younger candidates.

Conexiant